VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMW 2019 | Progression risk stratification of asymptomatic WM

Romanos Sklavenitis-Pistofidis, MD Dana-Farber Cancer Institute, Boston, MA, gives a brief outline of his work into the progression risk stratification of asymptomatic Waldenstrom macroglobulinemiaspeaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter